# Hester Biosciences

Poultry and large animal vaccines — Live attenuated, recombinant.

Source: https://cn.bioecon.ru/companies/hester-biosciences/
Updated: 2026-06-25

- 国家: India

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 产能 | 印度年产能6.25 billion剂（截至2024年3月31日），扩建项目预计2025年6月前实现约13.90 billion剂商业化产能 | https://www.careratings.com/upload/CompanyFiles/PR/202412121235_Hester_Biosciences_Limited.pdf |
| 认证 | 通过WHO-GMP、GLP、ISO 9001、ISO 14001及OHSAS 18001认证 | https://cdn.prod.website-files.com/628b3c79136f616e4ba82ff6/62a0d8694f492498620dee29_2016-17.pdf |
| 监管批准 | 获DSIR批准的研发单位；此前已获得BSL-3设施的监管批准 | https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/26072024/0cda3171-ca19-4c9c-b310-1ce8047a0ba0.pdf, https://cdn.prod.website-files.com/628b3c79136f616e4ba82ff6/62a0d8694f492498620dee29_2016-17.pdf, https://www.hester.in/about |
| 生产基地 | 印度古吉拉特邦Kadi、尼泊尔及坦桑尼亚 | https://valueortrap.substack.com/p/hester-biosciences-ltd, https://www.careratings.com/upload/CompanyFiles/PR/202412121235_Hester_Biosciences_Limited.pdf |
| 营收 | 7.7244亿印度卢比（合并口径，FY27 第一季度） | https://investoomarket.com/news/hester-biosciences-reports-q1-fy27-results-consolidated-profit-jumps-following-loan-amendment-gain.46982/ |

独立来源: bsmedia.business-standard.com, careratings.com, cdn.prod.website-files.com, investoomarket.com, valueortrap.substack.com

## 技术

- [兽医生物技术与 mRNA 兽药](https://cn.bioecon.ru/technology/veterinary-biotech-mrna-drugs/)